Single center, open label dose escalating trial evaluating once weekly oral ixazomib in ART-suppressed, HIV positive adults and effects on HIV reservoir size in vivo.
暂无分享，去创建一个
M. Lichterfeld | Shaji K. Kumar | E. Garcia-Rivera | A. Badley | J. Baker | A. Landay | P. Dean | G. Laird | V. Rajkumar | A. Tande | S. Rizza | N. Cummins | J. Zeuli | S. Natesampillai | J. Martinson | M. Maynes | J. Whitaker | R. Chakraborty | C. Rivera | Yelizaveta Rassadkina | Maryam Mahmood | A. Krogman | E. Wonderlich | Y. Kuzmichev | K. Subramanian | K. Ritter | Ashton Krogman | Krupa Subramanian